Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells.
about
The role of adenosine 3':5'-cyclic monophosphate in the division of WI 38 cells. The cellular response to prostaglandin E1 and the effects of an cyclic adenosine 3':5'-cyclic monophosphate analogue and prostaglandin E1 on cell divisionInsulin-like activity of concanavalin A and wheat germ agglutinin--direct interactions with insulin receptors.Expression of adenylate cyclase, catecholamine receptor, and cyclic adenosine monophosphate-dependent protein kinase in synchronized culture of Chang's liver cells (S phase-membrane receptors-NaF stimulation).Emergence of insulin receptors on human lymphocytes during in vitro transformation.Interrelationship between adenylate cyclase activity, adenosine 3':5' cyclic monophosphate phosphodiesterase activity, adenosine 3':5' cyclic monophosphate levels, and growth of cells in culture.An effect of dexamethasone on adenosine 3',5'-monophosphate content and adenosine 3',5'-monophosphate phosphodiesterase activity of cultured hepatoma cells.Chinese hamster ovary cell population density affects intracellular concentrations of calcium-dependent regulator and ability of regulator to inhibit adenylate cyclase activity.Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in cultureThe role of cyclic AMP and calcium in cell activation.Adenosine 3': 5'-cyclic monophosphate in young and senescent human fibroblasts during growth and stationary phase in vitro. Effects of prostaglandine E1 and of adrenaline.Modulators of cyclic AMP in monolayer cultures of Y-79 retinoblastoma cells: partial characterization of the response with VIP and glucagon.Acidic phospholipid species inhibit adenylate cyclase activity in rat liver plasma membranes.
P2860
Q28363199-27222787-A434-4347-9156-846AE9AD3B07Q34211363-2F3C0CD9-6DFB-4241-8F42-B0D063583770Q34689916-B8320E66-7BA8-49D6-8AE8-9F32E4196EBBQ34728929-AAEBD210-C993-4317-9375-9BE1F00B5D7AQ34751993-21690772-6F09-4A6C-859B-A0C1A53C3248Q35898063-C76DB87E-4B88-44C6-AEBC-9C1DBF05DCB6Q37340245-6FB672A1-2449-4021-AAD0-FB0578EE0CC5Q37588450-B1151A0A-A98E-4325-9CA6-B592A3706E36Q39897439-F19690C4-09CE-4FA7-8777-06D19FF09BD1Q42438980-4480735A-7CD9-4630-A8A7-B7373F9BBD2BQ42453934-97704E67-20F8-45DB-9329-2617351B064AQ42853181-8A6865E2-3669-49C8-922C-BFE0C8EEF9A1
P2860
Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1971
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Conditions leading to enhanced ...... and malignant cultured cells.
@en
Conditions leading to enhanced ...... and malignant cultured cells.
@nl
type
label
Conditions leading to enhanced ...... and malignant cultured cells.
@en
Conditions leading to enhanced ...... and malignant cultured cells.
@nl
prefLabel
Conditions leading to enhanced ...... and malignant cultured cells.
@en
Conditions leading to enhanced ...... and malignant cultured cells.
@nl
P2860
P356
P1476
Conditions leading to enhanced ...... and malignant cultured cells.
@en
P2093
P2860
P304
P356
10.1073/PNAS.68.9.2127
P407
P577
1971-09-01T00:00:00Z